Recent
price
P/E
ratio
div
yld
7.45%
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.ALX Oncology Reports Third Quarter 2026 Financial Results and Provides Corporate Update
ALX Oncology to Present at Upcoming Investor Conferences
Blue Wave Fuels REIT Rally
Alexander's, Inc. (ALX) Q3 2026 Earnings Call Transcript
Alexander's Q3 Earnings Call Highlights
Alexander's (ALX) Lags Q3 FFO and Revenue Estimates
Alexander's Announces Third Quarter Financial Results
Alexander’s (NYSE:ALX) Share Price Breaks Above Two Hundred Day Moving Average – Should You Sell?
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
Alexander's Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
Mousetraps: 7 High-Yield REITs Risking Dividend Cuts
Alexander’s (NYSE:ALX) & Essential Properties Realty Trust (NYSE:EPRT) Head-To-Head Review
Alexander’s (NYSE:ALX) Stock Crosses Below 200 Day Moving Average – Should You Sell?
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Head-To-Head Analysis: Tritax Big Box REIT (OTCMKTS:TTBXF) vs. Alexander’s (NYSE:ALX)
ALX Oncology to Present at Upcoming Investor Conferences in September
Is Alexander's (ALX) Outperforming Other Finance Stocks This Year?
Best Momentum Stocks to Buy for August 11th
New Strong Buy Stocks for August 11th
Best Income Stocks to Buy for August 11th